Western Sydney Local Health District   Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01077479
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Professor Michael Bourke | Western Sydney Local Health District | Westmead Hospital, Western Sydney Local Health District | Westmead Institute for Medical Research | Zhonghua Chen,MD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Barrett Esophagus (Phase 4)

Esophageal Stenosis (Phase 4)

Hypercholesterolemia (Phase 2)

Insulin Resistance (Phase 2)

Metabolic Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8